GABBR1
Basic information
Region (hg38): 6:29555629-29633976
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodevelopmental disorder with language delay and variable cognitive abnormalities | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Dental; Musculoskeletal; Neurologic; Ophthalmologic | 36103875 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GABBR1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | |||||
missense | 37 | 44 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 5 | 41 | 11 | 3 |
Variants in GABBR1
This is a list of pathogenic ClinVar variants found in the GABBR1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-29555916-G-T | not specified | Uncertain significance (Oct 16, 2023) | ||
6-29555933-C-T | Likely benign (Jun 25, 2018) | |||
6-29556148-G-A | not specified | Uncertain significance (Apr 05, 2023) | ||
6-29556179-C-T | not specified | Uncertain significance (Oct 05, 2023) | ||
6-29556340-C-T | not specified | Likely benign (Feb 28, 2024) | ||
6-29559690-A-T | not specified | Uncertain significance (Jun 22, 2021) | ||
6-29588133-C-A | not specified | Uncertain significance (Jan 03, 2022) | ||
6-29588306-A-G | not specified | Uncertain significance (Apr 25, 2022) | ||
6-29588354-G-T | not specified | Uncertain significance (Sep 26, 2023) | ||
6-29588356-C-A | not specified | Uncertain significance (Jul 27, 2021) | ||
6-29588390-T-C | not specified | Uncertain significance (Mar 29, 2022) | ||
6-29588449-G-A | not specified | Uncertain significance (Mar 31, 2024) | ||
6-29588489-T-C | not specified | Uncertain significance (Dec 20, 2022) | ||
6-29588533-G-A | not specified | Likely benign (Jan 18, 2022) | ||
6-29588553-C-G | not specified | Uncertain significance (Dec 28, 2022) | ||
6-29588561-T-C | not specified | Uncertain significance (Mar 11, 2022) | ||
6-29588600-T-C | not specified | Uncertain significance (Dec 17, 2021) | ||
6-29588621-T-C | not specified | Uncertain significance (Jun 28, 2023) | ||
6-29588629-G-A | not specified | Uncertain significance (Jul 12, 2022) | ||
6-29588855-G-C | not specified | Uncertain significance (Jan 26, 2022) | ||
6-29603565-C-T | not specified | Uncertain significance (Jun 22, 2021) | ||
6-29603586-C-T | not specified | Uncertain significance (Oct 18, 2021) | ||
6-29603590-C-T | not specified | Uncertain significance (Jul 13, 2022) | ||
6-29603599-C-T | not specified | Uncertain significance (May 04, 2022) | ||
6-29603604-G-A | not specified | Uncertain significance (Jan 10, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GABBR1 | protein_coding | protein_coding | ENST00000377034 | 22 | 78348 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.0000879 | 125737 | 0 | 11 | 125748 | 0.0000437 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 4.82 | 236 | 556 | 0.425 | 0.0000324 | 6213 |
Missense in Polyphen | 77 | 246.31 | 0.31262 | 2681 | ||
Synonymous | 0.887 | 204 | 221 | 0.924 | 0.0000126 | 1941 |
Loss of Function | 5.98 | 6 | 53.0 | 0.113 | 0.00000279 | 567 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000313 | 0.000308 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000272 | 0.0000264 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of a heterodimeric G-protein coupled receptor for GABA, formed by GABBR1 and GABBR2 (PubMed:9872316, PubMed:9872744, PubMed:15617512, PubMed:18165688, PubMed:22660477, PubMed:24305054). Within the heterodimeric GABA receptor, only GABBR1 seems to bind agonists, while GABBR2 mediates coupling to G proteins (PubMed:18165688). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase (PubMed:10906333, PubMed:10773016, PubMed:10075644, PubMed:9872744, PubMed:24305054). Signaling inhibits adenylate cyclase, stimulates phospholipase A2, activates potassium channels, inactivates voltage-dependent calcium-channels and modulates inositol phospholipid hydrolysis (PubMed:10075644). Calcium is required for high affinity binding to GABA (By similarity). Plays a critical role in the fine-tuning of inhibitory synaptic transmission (PubMed:9844003). Pre-synaptic GABA receptor inhibits neurotransmitter release by down-regulating high-voltage activated calcium channels, whereas postsynaptic GABA receptor decreases neuronal excitability by activating a prominent inwardly rectifying potassium (Kir) conductance that underlies the late inhibitory postsynaptic potentials (PubMed:9844003, PubMed:9872316, PubMed:10075644, PubMed:9872744, PubMed:22660477). Not only implicated in synaptic inhibition but also in hippocampal long-term potentiation, slow wave sleep, muscle relaxation and antinociception (Probable). Activated by (-)-baclofen, cgp27492 and blocked by phaclofen (PubMed:9844003, PubMed:9872316, PubMed:24305054). {ECO:0000250|UniProtKB:Q9Z0U4, ECO:0000269|PubMed:10075644, ECO:0000269|PubMed:10773016, ECO:0000269|PubMed:10906333, ECO:0000269|PubMed:15617512, ECO:0000269|PubMed:18165688, ECO:0000269|PubMed:22660477, ECO:0000269|PubMed:24305054, ECO:0000269|PubMed:9844003, ECO:0000269|PubMed:9872316, ECO:0000269|PubMed:9872744, ECO:0000305}.;
- Pathway
- GABAergic synapse - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Estrogen signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Taste transduction - Homo sapiens (human);Morphine addiction - Homo sapiens (human);GPCRs, Class C Metabotropic glutamate, pheromone;Signaling by GPCR;Signal Transduction;Neuronal System;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding;Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits;Activation of GABAB receptors;GABA B receptor activation;GABA receptor activation;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;G alpha (i) signalling events;Activation of G protein gated Potassium channels;GPCR downstream signalling;G protein gated Potassium channels;Inwardly rectifying K+ channels;Potassium Channels
(Consensus)
Intolerance Scores
- loftool
- 0.0575
- rvis_EVS
- -0.43
- rvis_percentile_EVS
- 25.37
Haploinsufficiency Scores
- pHI
- 0.0662
- hipred
- Y
- hipred_score
- 0.631
- ghis
- 0.564
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.809
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gabbr1
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- gabbr1b
- Affected structure
- behavioral response to nicotine
- Phenotype tag
- abnormal
- Phenotype quality
- decreased occurrence
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway;negative regulation of adenylate cyclase activity;gamma-aminobutyric acid signaling pathway;regulation of postsynaptic membrane potential
- Cellular component
- extracellular region;cytoplasm;plasma membrane;integral component of plasma membrane;cell junction;dendrite;G protein-coupled receptor heterodimeric complex;presynaptic membrane;postsynaptic membrane;Schaffer collateral - CA1 synapse;GABA-ergic synapse
- Molecular function
- G protein-coupled GABA receptor activity;protein binding;G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential